688276 Stock Overview
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Changchun BCHT Biotechnology Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥39.75 |
| 52 Week High | CN¥71.79 |
| 52 Week Low | CN¥40.00 |
| Beta | -0.12 |
| 1 Month Change | -15.75% |
| 3 Month Change | -21.80% |
| 1 Year Change | -40.36% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -66.46% |
Recent News & Updates
Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Apr 16
We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings
Mar 30Shareholder Returns
| 688276 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -4.4% | -3.8% | -0.4% |
| 1Y | -40.4% | -26.7% | -16.2% |
Return vs Industry: 688276 underperformed the CN Biotechs industry which returned -26.7% over the past year.
Return vs Market: 688276 underperformed the CN Market which returned -16.2% over the past year.
Price Volatility
| 688276 volatility | |
|---|---|
| 688276 Average Weekly Movement | 6.8% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 688276's share price has been volatile over the past 3 months.
Volatility Over Time: 688276's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,241 | Wei Kong | www.bchtpharm.com |
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. Its products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. The company was founded in 2004 and is based in Changchun, China.
Changchun BCHT Biotechnology Co. Fundamentals Summary
| 688276 fundamental statistics | |
|---|---|
| Market cap | CN¥16.72b |
| Earnings (TTM) | CN¥543.19m |
| Revenue (TTM) | CN¥1.92b |
30.2x
P/E Ratio8.6x
P/S RatioIs 688276 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688276 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.92b |
| Cost of Revenue | CN¥212.81m |
| Gross Profit | CN¥1.70b |
| Other Expenses | CN¥1.16b |
| Earnings | CN¥543.19m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.32 |
| Gross Margin | 88.89% |
| Net Profit Margin | 28.36% |
| Debt/Equity Ratio | 1.6% |
How did 688276 perform over the long term?
See historical performance and comparison